eMed

Start Testing
Order Now
Login

Travel
TEST-TO-TREAT™
Employers
News
About
Support
Login
Shop

English
Español

English

eMed Co-Founder and CEO, Dr. Patrice Harris, will Host Fireside Chat with U.S. Surgeon General Dr. Vivek H. Murthy at eMerge Americas 2022

Additionally, Miami-based eMed exhibit at the premier global tech conference showcasing its Test-to-Treat™ technology...

eMed’s Test-to-Treat™ Program Aligned with President Biden as Key Element in the Next Phase of the Pandemic Response

eMed

eMed’s Virtually Guided Program Enables Fast Access to Treatment for COVID-19 for Millions of Americans

eMed Names Accomplished Private Equity Investor Michael Cole as Chief Financial Officer

eMed

With Omicron Surging Amid the Holiday Rush, We Need to Rethink COVID-19 Testing for Travel

Dr. Michel Mina, Chief Science Officer, eMed

The Promise of Digital Health at CES

Dr. Michel Mina, Chief Science Officer, eMed

eMed and Hollywood A-Lister to Partner on Campaign to Enable Americans with Access to At-Home Testing and Therapeutics

eMed Announces Multimillion Dollar PSA Campaign at CES to Keep America Healthy

eMed

eMed and Hollywood A-Lister to Partner on Campaign to Enable Americans with Access to At-Home Testing and Therapeutics

1 2

Leave Feedback

Search All Blog Posts

Subscribe to Our Blog

Most Popular

Language

English

Select your preferred language

Cancel

About
Our Team
Contact
Careers
News
Blog

Legal

Terms of Use
Terms of Sale
Privacy Policy
Notice of Privacy Practices
EUA Disclaimer
Quick Reference Instructions

This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA;

This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and,

This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection
and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.